Source and study location | Survey period | Estimated prevalence per 1000 (95% CI) | ||
---|---|---|---|---|
Previously diagnoseda | Diagnosed by spirometryb | Firstly diagnosed by spirometryc | ||
Menezes AM et al. Montevideo, Uruguay (PLATINO study) [20] | 2002 | ND | 197 (172–222) | ND |
Menezes AM et al. Mexico City, Mexico (PLATINO study) [20] | 2002 | ND | 78 (59–97) | ND |
Doney B et al. USA [19] | 2004–2011 | ND | 42 (40–43) | ND |
Buist AS et al.12 sites across Europe, Asia, USA, Canada, South Africa and Australia (BOLD study) [7] | 2005–2007 | ND | 193 (ND) | ND |
Bárbara C et al. Lisbon, Portugal [28] | 2006–2007 | ND | 142 (111–181) | ND |
Danielsson P et al. Uppsala, Sweden (BOLD study) [34] | 2006–2007 | ND | 162 (CI: ND) | ND |
Minas M et al. Greece [15] | 2006–2007 | 57 (CI: ND) | 184 (CI: ND) | 127 (CI: ND) |
Soriano JB et al. Spain [16] | 2007 | ND | 45 (24–66) | ND |
Vanfleteren LE et al. Maastricht, Netherlands [23] | 2007–2009 | 88 (CI: ND) | 240 (CI: ND) | ND |
Carlsson AC et al. Stockholm, Sweden [21] | 2007–2011 | 18 (CI: ND) | ND | ND |
Yoo KH et al. South Korea [17] | 2008 | ND | 134 (CI: ND) | ND |
Sousa CA et al. São Paulo, Brazil [25] | 2008–2009 | 42 (31–54) | ND | ND |
Al Zaabi A et al. Abu Dhabi, United Arab Emirates [22] | 2009–2010 | ND | 37 (20–53) | ND |
Lâm HT et al. Northern Vietnam [18] | 2009–2010 | ND | 71 (CI: ND) | ND |
Chuchalin AG et al. Russia (GARD Study) [26] | 2010–2011 | 222 (212–232) | 218 (195–245) | ND |
Van Gemert F et al. Uganda [27] | 2012 | ND | 162 (CI: ND) | ND |
Tageldin MA et al. Middle East and North Africa (BREATHE study) [35] | 2012 | 36 (35–37) | ND | ND |